| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $315M | — | — | — | — |
| Op. Income | $40M | — | — | — | — |
| Gross Margin | 36.1% | — | — | — | — |
| Net Margin | 5.8% | — | — | — | — |
| EPS (Diluted) | $0.09 | — | — | — | — |
| Free Cash Flow | -$122M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $315M |
| Cost of Revenue | $202M |
| GROSS PROFIT | $114M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $74M |
| Operating Expenses | $74M |
| Cost & Expenses | $275M |
| OPERATING INCOME | $40M |
| Interest Income | $0 |
| Interest Expense | $26M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | $21M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $18M |
| Net Income from Discontinued Ops | -$1.0K |
| Other Adjustments | $0 |
| NET INCOME | $18M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $18M |
| D&A | $52M |
| EBIT | $47M |
| EBITDA | $99M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $315M |
| Cost of Revenue | $202M |
| GROSS PROFIT | $114M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $74M |
| Operating Expenses | $74M |
| Cost & Expenses | $275M |
| OPERATING INCOME | $40M |
| Interest Income | $0 |
| Interest Expense | $26M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | $21M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $18M |
| Net Income from Discontinued Ops | -$1.0K |
| Other Adjustments | $0 |
| NET INCOME | $18M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $18M |
| D&A | $52M |
| EBIT | $47M |
| EBITDA | $99M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $18M |
| Depreciation & Amortization | $52M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $7M |
| Other Non-Cash Items | -$5M |
| Change in Working Capital | -$16M |
| OPERATING CASH FLOW | $58M |
| Capital Expenditure | -$180M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$6M |
| NET CASH FROM INVESTING | -$185M |
| Net Debt Issuance | $171M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$27M |
| Other Financing Activities | -$215.0K |
| NET CASH FROM FINANCING | $144M |
| FREE CASH FLOW | -$122M |
| Net Change in Cash | $17M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $76M |
| Short-Term Investments | $0 |
| Net Receivables | $132M |
| Inventory | $44M |
| Other Current Assets | $249M |
| TOTAL CURRENT ASSETS | $501M |
| PP&E (Net) | $5.6B |
| Goodwill | $346M |
| Intangible Assets | $0 |
| Long-Term Investments | $118M |
| Tax Assets | $0 |
| Other Non-Current Assets | $629M |
| TOTAL NON-CURRENT ASSETS | $6.7B |
| TOTAL ASSETS | $7.2B |
| Account Payables | $122M |
| Short-Term Debt | $165M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $175M |
| TOTAL CURRENT LIABILITIES | $667M |
| Long-Term Debt | $2.2B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $434M |
| Other Non-Current Liabilities | $1.2B |
| TOTAL NON-CURRENT LIABILITIES | $3.8B |
| TOTAL LIABILITIES | $4.5B |
| Common Stock | $204M |
| Additional Paid-In Capital | $1.5B |
| Retained Earnings | $1.1B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$16M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.7B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.7B |
| TOTAL LIABILITIES & EQUITY | $7.2B |
| Total Debt | $2.4B |
| Net Debt | $2.3B |
